Overview
ASTM C1473-19 establishes a standard test method for the radiochemical determination of uranium isotopes in urine using alpha spectrometry. Developed by ASTM International, this method provides a reliable protocol for detecting and measuring uranium exposure among occupational workers. It is widely used as a screening tool for monitoring internal contamination, particularly in environments where personnel may come into contact with uranium compounds. The standard also references best practices for laboratory safety and emphasizes adherence to international guidelines.
Key Topics
- Radiochemical Testing: The standard outlines detailed procedures for preparing urine samples, separating uranium isotopes, and performing measurement via alpha spectrometry.
- Occupational Uranium Exposure: Designed to detect exposure risks in the workplace, it helps in evaluating whether workers have been exposed to uranium isotopes which are excreted via urine.
- Sample Volume: The method specifically addresses 50 mL urine samples. However, detection sensitivity can be affected by sample volume, count time, detector background, and tracer yield.
- Safety Requirements: Users are responsible for implementing appropriate safety, health, and environmental controls, particularly when handling hazardous reagents such as acids and biological materials.
- Interfering Substances: The standard highlights potential interferences, such as the inability to resolve certain uranium isotope energies and the presence of substances like neptunium.
- Calibration and Standardization: Utilizes uranium-232 as a yield tracer and details the need for proper calibration to achieve reliable results.
Applications
- Health Physics and Occupational Safety: The primary application is in health physics monitoring programs, especially in nuclear, radiological, and heavy industry settings. Facilities processing uranium or employing such materials rely on this method for routine bioassays of workers.
- Medical Surveillance: Medical laboratories and occupational health clinics use this protocol to assess exposure levels in potentially affected individuals.
- Regulatory Compliance: Organizations must often meet regulatory requirements for monitoring internal radiation exposure; this standard helps demonstrate compliance via scientifically validated measurement techniques.
- Environmental and Emergency Response: In the event of accidental releases or suspected contamination incidents, this method supports rapid screening for uranium uptake among exposed workers.
Related Standards
For comprehensive uranium bioassay and alpha spectrometry practices, ASTM C1473-19 references and relates to the following standards:
- ASTM C1844: Test method for determining uranium in urine using inductively coupled plasma mass spectrometry (ICP-MS).
- ASTM C1000: Radiochemical determination of uranium isotopes in soil by alpha spectrometry.
- ASTM C1163 & C1284: Practices for mounting and electrodeposition of actinides for alpha spectrometry.
- ASTM D1193: Specification for reagent water, crucial for laboratory procedures.
- ASTM D3084 & D3972: Methods and practices for alpha-particle spectrometry and isotopic uranium testing in water.
- ASTM D3648: Practices for measuring radioactivity in various matrices.
Practical Value
Implementing ASTM C1473-19 ensures high-confidence results in uranium bioassays, supporting worker safety programs and regulatory obligations in nuclear, defense, mining, and environmental sectors. The use of alpha spectrometry enables sensitive detection of uranium isotopes, helping identify and manage occupational exposures before they become health concerns. The standard is designed for reproducibility, traceability, and compatibility with internationally recognized quality and safety practices aligned with WTO directives.
Keywords: alpha spectrometry, uranium isotopes, urine bioassay, radiochemical method, occupational uranium exposure, ASTM C1473-19, laboratory safety, uranium screening, nuclear worker health monitoring.